Papers/PMID:27865190
Effect of potassium supplementation on vascular function: A meta-analysis of randomized controlled trials.
International journal of cardiology2017The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
K(+) — no detected effect on flow-mediated dilation
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Pooling results revealed a significant improvement in PP (SMD -0.280, 95% CI -0.493 to -0.067, p=0.010), but no improvement in PWV (SMD -0.342, 95% CI -1.123 to 0·440, p=0.391), AI (SMD -0.114, 95% CI -0.282 to 0.054, p=0.184), FMD (SMD 0·278, 95% CI -0.321 to 0.877, p=0.363), GTN (SMD -0.009, 95% CI -0.949 to 0.930, p=0.984), and ICAM-1 (SMD -0.238, 95% CI -0.720 to 0.244, p=0.333).”
Quoted verbatim from Effect of potassium supplementation on vascular function: A meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Dose
- 40 to 150 mmol/day across trials
- Population
- Participants in seven randomised trials of potassium supplementation (40 to 150 mmol/day, 6 days to 12 months)
Effect 0.278 standardised mean difference, 95% CI -0.321 to 0.877
Effect of potassium supplementation on vascular function: A meta-analysis of randomized controlled trials.2017PMID:27865190Permalink